The company has sought an early meeting of the subject expert committee on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) to take a decision on its application

Terming the second wave as 'concerning and scaring', Chandrasekaran also called for accelerated tracing and vaccination and tracking supply of the vaccines while asserting that a nationwide lockdown is not the solutionas it would hit the economy hard

The announcement comes after South Korean biotech firm GL Rapha signed a deal with Russia's sovereign wealth fund late last year to make more than 150 million doses of Sputnik V per year

Air India looking to hire CEOs for its subsidiaries National carrier Air India has sought applications for the post of chief executive officer (CEO) for its subsidiaries Air India Engineering Services Ltd (AIESL), Air India Airport Services Ltd (AIASL) and Alliance Air Aviation Ltd (AAAL). The selected candidates will be hired for a contract period of three years, extendable by two years based on performance.Flipkart to take over Cleartrip in distress saleFlipkart will acquire embattled t...

A waiver would boost vaccine manufacturing and speed up the response to the pandemic in poorer countries which otherwise might have to wait years, they said in a joint letter to Biden sent to news organisations on Wednesday

Stocks to watch today: Infosys, Motherson Sumi Systems, Tata Motors, Bharti Airtel and more

Addressing a virtual press briefing on April 13, Dmitriev said its vaccine partnership covers 20 producers in 10 countries including Korea, China and India

The company has got permission from the Drug Controller General of India (DCGI) to import the vaccine. Reddy's is also going to tap domestically contract manufactured vaccines as and when companies are allowed to start commercial manufacturing in India

COVID-19 update in India: Maharashtra, Uttar Pradesh, Madhya Pradesh, Karnataka, Kerala, Gujarat, Rajasthan, Chhattisgarh, Tamil Nadu and Delhi are the ten states that account for 82.04 per cent of the fresh coronavirus infections in the country

Rahul Gandhi tweeted, citing Mahatma Gandhi's quote: 'First they ignore you. Then they laugh at you. Then they fight you. Then you win'. He also tagged a media report, saying the Centre has fast-tracked emergency approval for foreign-produced jabs.

SC asked all Controlling Officers to ensure that the staff in their control wear mask, maintain physical distancing and frequently sanitise/wash hands.

Coronavirus vaccination: After taking the first shot, the vaccine beneficiary will receive a message on his/her registered mobile number about the link to download the vaccination certificate

Yogi says all activities of government are being conducted normally. As coronavirus cases rise at a rapid pace in UP, other leaders have also tested positive for deadly virus. Earlier today, SP chief Akhilesh Yadav and UP minister Ashutosh Tandon also tested positive for COVID-19

The vaccine maker said the six-month follow-up of its original late-stage study of the vaccine showed that vaccine efficacy remained consistent with its previous updates

A total of 82,339 patients were discharged in the past 24 hours. As of April 14, India's total case tally stands at 1.38 crore; total recoveries 1.2 crore; active cases 13.6 lakh; and 1.72 lakh patients have died

Drug major Dr Reddy's Laboratories is also going to tap domestically sourced jabs as their production speeds up in India

Russian Direct Investment Fund (RDIF) CEO Kirill Dmitriev added that Sputnik V's production at a larger scale will start by July 2021 with plans to produce 500 million doses

India is the leading production hub for Sputnik V. RDIF has signed pacts with Gland Pharma, Hetero Biopharma, Panacea Biotec, Stelis Biopharma, Virchow Biotech to produce over 850 million doses per year

Russia's Sputnik V COVID-19 vaccine, with an effectiveness of 91.6 per cent, has been approved for restricted use in India, sources within the drug regulator's office confirmed the development on Monday. The approval to the vaccine was given based on 'very strong immunogenicity data'. Sputnik V has been developed by the Gamaleya Research Institute of Epidemiology and Microbiology in Russia. The vaccine demonstrated an efficacy rate of 91.6 per cent in the interim analysis of the phase 3 clinical trial in Russia. In February 2021, Dr Reddy's applied for the emergency use of the Russian vaccine in India. Watch the video for more.Also Read: Russia's COVID-19 vaccine Sputnik V gets govt's nod

Developed by Russia's Gamaleya national center of epidemiology and microbiology, Sputnik V is the third COVID-19 vaccine approved by the Subject Expert Committee (SEC) after Covishield and Covaxin